1. Which of the following statements regarding cefovecin (Convenia®) injection is correct?
A. Cefovecin achieves its long duration of action in dogs and cats through a nanoparticle carrier system.
B. Cefovecin is the antibiotic of choice for suspected Pseudomonas infections in dogs and cats.
C. Cefovecin is administered by injection only.
D. Cefovecin does not interfere with binding of highly protein-bound drugs.
2. Enrofloxacin is relatively contraindicated in cats because:
A. It crosses the blood–brain barrier in cats and causes severe central nervous system reactions, including seizures.
B. Inefficient glucuronide conjugation in cats leads to accumulation of toxic enrofloxacin metabolites, causing nephrotoxicity.
C. A defect in the transporter pump at the blood–aqueous barrier in cats allows enrofloxacin to enter the inner eye, causing retinal damage and blindness.
D. It causes premature closure of the cartilage growth plates in mature cats and thus should not be used in cats older than 2 years of age.
3. Which of the following fluoroquinolones is not approved for use in dogs in the United States?
A. Enrofloxacin
B. Marbofloxacin
C. Orbifloxacin
D. Pradofloxacin
4. Which of the following statements about florfenicol is correct?
A. Florfenicol is not used in cats because the vehicle contains 15% propylene glycol, which may cause Heinz body anemia in cats.
B. Florfenicol is indicated for the treatment of respiratory infections in horses.
C. Like chloramphenicol, florfenicol may cause aplastic anemia.
D. Florfenicol must be metabolized via conjugation with glucuronide and has a longer half-life in cats than in dogs.
5. Which of the following NSAIDs is most appropriate for use in cats, based on the adverse event profile?
A. Carprofen
B. Deracoxib
C. Firocoxib
D. Robenacoxib
6. Which of the following statements regarding flunixin meglumine is correct?
A. It is available only as an injection because it is not orally bioavailable.
B. It is harmful to aquatic organisms and should not be allowed to reach ground water, water course, or sewage or drainage systems.
C. It is used commonly as an ocular analgesic in horses with fungal eye ulcers.
D. When administered by injection, it always should be administered by the intramuscular route.
7. Which of the following NSAIDs approved for use in dogs in the United States is available in a dosage form that is not flavored with beef?
A. Carprofen
B. Deracoxib
C. Firocoxib
D. Robenacoxib
8. Why isn't pradofloxacin approved for use in dogs in the United States?
A. It causes bone marrow suppression.
B. It causes erosion of cartilage and premature closure of growth plates.
C. It causes retinal toxicity and blindness.
D. It must be acetylated to be eliminated and dogs cannot perform acetylation.
9. Which statement regarding tilmicosin is correct?
A. Tilmicosin should be administered by intravenous injection only, because intramuscular injection causes tissue necrosis.
B. Tilmicosin may cause sudden death following intravenous administration in many species, including humans.
C. Tilmicosin is approved as Pulmotil? for administration via inhalation to treat pneumonia in swine.
D. Tilmicosin is FDA-approved for use in cattle, sheep, swine, rabbits, and dogs.
10. Which of the following combinations of active ingredients is present in Osurnia® Otic Gel?
A. Cefovecin, carprofen, hydrocortisone
B. Enrofloxacin, silversulfadiazine, prednisolone
C. Florfenicol, terbinafine, betamethasone.
D. Robenacoxib, marbofloxacin, ketoconazole
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
